Document is current
Any future updates will be listed below
-
Authors
Yanagisawa, Takafumi
Mori, Keiichiro
Matsukawa, Akihiro
Kawada, Tatsushi
Katayama, Satoshi
Laukhtina, Ekaterina
Rajwa, Pawel
Quhal, Fahad
Pradere, Benjamin
Fukuokaya, Wataru
Iwatani, Kosuke
Pichler, Renate
Teoh, Jeremy Yuen-Chun
Moschini, Marco
Krajewski, Wojciech
Miki, Jun
Shariat, Shahrokh F.
Kimura, Takahiro
,
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 30 January 2024
Accepted: 29 November 2024
First Online: 1 February 2025
Declarations
:
: Takahiro Kimura is a paid consultant/advisor of Astellas, Bayer, Janssen and Sanofi. Shahrokh F. Shariat received follows: Honoraria: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Roche, Takeda Consulting or Advisory Role: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Pierre Fabre, Roche, Takeda Speakers Bureau: Astellas, Astra Zeneca, Bayer, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Richard Wolf, Roche, Takeda The other authors declare no conflicts of interest associated with this manuscript.
: N/A.
: N/A.
